Member Exclusive News

The week in industry: Evotec and Takeda plan to develop five drug discovery programs

The first GLP-1 analog in a pill for adults with diabetes gets FDA approval, St George Street Capital (Hertfordshire, UK) signs a deal with AstraZeneca (Cambridge, UK) and H.E.L Group (Hertfordshire, UK) receives investment of US$7.3 million to advance product innovation.

Go to the profile of RxNet
Sep 26, 2019

Please sign in or register for FREE

No comments yet.